National Health Investors, Inc. Q3 2025 Earnings Recap

NHI Q3 2025 November 9, 2025

National Health Investors reported a robust third quarter with a notable 63% increase in SHOP NOI, bolstered by strategic property transitions and a strong acquisition pipeline, leading to a third upward revision in annual guidance.

Earnings Per Share Beat

$1.32 vs $1.24 est.

+6.5% surprise

Revenue Miss

89847000 vs 95120680 est.

-5.5% surprise

Market Reaction

1-Day -0.1%

5-Day +0.46%

30-Day +2.92%

Key Takeaways

SHOP NOI growth of approximately 63% year-over-year, driven by the transition of 7 properties.
First SHOP acquisition completed for $74.3 million, expected to yield an NOI of 8.2%.
Full-year guidance raised for a projected NFFO per share growth of over 10%, marking the strongest growth since 2014.
A solid pipeline of acquisitions valued at $195 million under signed Letters of Intent, anticipated to close in late 2025 and early 2026.
Financial health remains strong with a net debt to adjusted EBITDA of 3.6x and over $1 billion in available liquidity, providing a competitive advantage.

This summary was generated by AI from the official earnings call transcript and is provided for informational purposes only. It does not constitute financial advice. For the complete transcript and financial data, visit NHI on AllInvestView.